PAVmed Inc. (PAVM) › Cash & EquivalentsPAVmed Inc. (PAVM) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2014: $839.1K2015: $767.3K2016: $585.7K2017: $1.54M2018: $8.22M2019: $6.22M2020: $17.26M2021: $77.26M2022: $39.74M2023: $19.64M2024: $1.19M2025: $1.54M$1.54M2014Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$1.54M+29.8%2024$1.19M-94.0%2023$19.64M-50.6%2022$39.74M-48.6%2021$77.26M+347.7%2020$17.26M+177.5%2019$6.22M-24.4%2018$8.22M+435.6%2017$1.54M+162.1%2016$585.7K-23.7%2015$767.3K-8.6%2014$839.1K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share